4823
Gene Therapy for Primary Immunodeficiency Disorders: Where are We in 2014?
Monday, March 3, 2014: 4:45 PM-5:45 PM
Marriott South Tower, Level 3, Mission Hills
1.00 CME/ 1.20 CE
Primary Discussion Leaders:
Matthew Porteus , MD PhD
Fabio Candotti , MD
Learning Objectives:
  1. Review the primary immunodeficiency disorders for which gene therapy is a treatment option
  2. Discuss the mechanism of gene therapy
  3. Discuss limitations and risks associated with gene therapy
See more of: Seminar